- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.29 Å
- Oligo State
- homo-tetramer
- Ligands
- 17 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x SAO: 5'-S-[(3S)-3-azaniumyl-3-carboxypropyl]-5'-thioadenosine(Non-covalent)
SAO.7: 28 residues within 4Å:- Chain A: F.12, R.15, Y.24, F.25, Y.28, Q.34, M.37, R.43, D.65, G.67, C.68, G.69, S.70, G.71, I.72, L.73, V.88, E.89, A.90, S.91, G.115, K.116, V.117, E.118, E.132, P.133, M.143, S.146
14 PLIP interactions:14 interactions with chain A- Hydrogen bonds: A:Q.34, A:G.67, A:G.69, A:E.89, A:A.90, A:S.91, A:S.91, A:V.117, A:E.118
- Water bridges: A:R.15, A:G.71, A:E.132
- Salt bridges: A:R.43
- pi-Stacking: A:F.25
SAO.18: 28 residues within 4Å:- Chain C: F.12, R.15, Y.24, F.25, Y.28, Q.34, M.37, R.43, D.65, G.67, C.68, G.69, S.70, G.71, I.72, L.73, V.88, E.89, A.90, S.91, G.115, K.116, V.117, E.118, E.132, P.133, M.143, S.146
13 PLIP interactions:13 interactions with chain C- Hydrogen bonds: C:Q.34, C:G.67, C:E.89, C:E.89, C:A.90, C:S.91, C:V.117, C:E.118
- Water bridges: C:R.15, C:G.71, C:E.132
- Salt bridges: C:R.43
- pi-Stacking: C:F.25
- 1 x PE8: 3,6,9,12,15,18,21-HEPTAOXATRICOSANE-1,23-DIOL(Non-covalent)
- 2 x 78V: 4-[2-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methylamino]ethylamino]-1-(methoxymethyl)pyrimidin-2-one(Non-covalent)
78V.11: 31 residues within 4Å:- Chain B: F.12, R.15, Y.24, F.25, F.27, Y.28, Q.33, Q.34, M.37, G.67, C.68, G.69, V.88, E.89, A.90, S.91, G.115, K.116, V.117, E.118, E.132, P.133, M.134, G.135, Y.136, E.141, M.143, S.146, H.289, W.290
- Ligands: EDO.9
9 PLIP interactions:9 interactions with chain B- Hydrogen bonds: B:Q.34, B:E.89, B:E.89, B:A.90, B:V.117, B:E.118, B:E.141
- Water bridges: B:R.15
- pi-Stacking: B:F.25
78V.22: 29 residues within 4Å:- Chain D: F.12, R.15, Y.24, F.25, F.27, Y.28, Q.33, Q.34, M.37, G.67, G.69, V.88, E.89, A.90, S.91, G.115, K.116, V.117, E.118, E.132, P.133, M.134, G.135, Y.136, E.141, M.143, S.146, H.289, W.290
11 PLIP interactions:11 interactions with chain D- Hydrogen bonds: D:Q.34, D:G.69, D:E.89, D:E.89, D:A.90, D:S.91, D:V.117, D:E.118, D:E.141
- Water bridges: D:R.15
- pi-Stacking: D:F.25
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Halby, L. et al., Hijacking DNA methyltransferase transition state analogues to produce chemical scaffolds for PRMT inhibitors. Philos.Trans.R.Soc.Lond.B Biol.Sci. (2018)
- Release Date
- 2017-09-20
- Peptides
- Histone-arginine methyltransferase CARM1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.29 Å
- Oligo State
- homo-tetramer
- Ligands
- 17 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x SAO: 5'-S-[(3S)-3-azaniumyl-3-carboxypropyl]-5'-thioadenosine(Non-covalent)
- 1 x PE8: 3,6,9,12,15,18,21-HEPTAOXATRICOSANE-1,23-DIOL(Non-covalent)
- 2 x 78V: 4-[2-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methylamino]ethylamino]-1-(methoxymethyl)pyrimidin-2-one(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Halby, L. et al., Hijacking DNA methyltransferase transition state analogues to produce chemical scaffolds for PRMT inhibitors. Philos.Trans.R.Soc.Lond.B Biol.Sci. (2018)
- Release Date
- 2017-09-20
- Peptides
- Histone-arginine methyltransferase CARM1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D